Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quotient in RapidFACT Pact with Pulmatrix | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quotient in RapidFACT Pact with Pulmatrix

Will manufacture spray-dried product for Phase I COPD trial

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quotient Clinical has entered into a collaboration with Pulmatrix, Inc. to support the development of PUR0200, a new bronchodilator therapy for the treatment of COPD. It’s the first small molecule product from Pulmatrix’s inhaled iSPERSE technology platform.
 
Quotient will employ its RapidFACT (Rapid Formulation development And Clinical Testing) service to manufacture the spray dried PUR0200 product to support the Phase Ib trial in COPD patients. This capability allows within-protocol adjustment of the formulation composition for any arising safety, pharmacokinetic and pharmacodynamic data to optimize performance. The study will take place at Quotient’s site in Nottingham, UK.
 
Mark Egerton, managing director of Quotient Clinical, said,  “We are delighted that Pulmatrix has chosen to utilize our RapidFACT service to support the development PUR0200. We have proven that RapidFACT can shorten timelines and reduce costs in early development, which ultimately contributes to enhancing R&D productivity. This particular study also demonstrates our ability to manufacture and supply drug product in real time to other clinical centers of excellence that specialize in specific disease indications and endpoints.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics